Jeffrey T. Chang

16.1k total citations · 2 hit papers
109 papers, 9.5k citations indexed

About

Jeffrey T. Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jeffrey T. Chang has authored 109 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 38 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Jeffrey T. Chang's work include Cancer Cells and Metastasis (20 papers), Bioinformatics and Genomic Networks (15 papers) and Cancer Genomics and Diagnostics (11 papers). Jeffrey T. Chang is often cited by papers focused on Cancer Cells and Metastasis (20 papers), Bioinformatics and Genomic Networks (15 papers) and Cancer Genomics and Diagnostics (11 papers). Jeffrey T. Chang collaborates with scholars based in United States, China and United Kingdom. Jeffrey T. Chang's co-authors include Brad Chapman, Joseph R. Nevins, Peter Cock, Frank Kauff, Bartek Wilczyński, Iddo Friedberg, Cymon J. Cox, Tiago Antão, Thomas Hamelryck and Michiel de Hoon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jeffrey T. Chang

102 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biopython: freely available Python tools for computational molecular biology and bioinformatics

2009 3.5k citations Jeffrey T. Chang et al. profile →
Oncogenic pathway signatures in human cancers as a guide to targeted therapies

2005 1.5k citations Andrea Bild, Guang Yao et al. profile →

Peers

Countries citing papers authored by Jeffrey T. Chang

Since Specialization

Citations

This map shows the geographic impact of Jeffrey T. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey T. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey T. Chang more than expected).

Fields of papers citing papers by Jeffrey T. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey T. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey T. Chang. The network helps show where Jeffrey T. Chang may publish in the future.

Co-authorship network of co-authors of Jeffrey T. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey T. Chang. A scholar is included among the top collaborators of Jeffrey T. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey T. Chang. Jeffrey T. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer 2025 ·Molecular Systems Biology ·Jason I. Griffiths, Feng Chi, Elena Farmaki, (unknown), Patrick A. Cosgrove, (unknown), Jinfeng Chen, Vince Kornél Grolmusz, Frederick R. Adler, Qamar J. Khan, Aritro Nath, Jeffrey T. Chang, Andrea Bild	0
2	Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers 2025 ·Nature Communications ·Jason I. Griffiths, Patrick A. Cosgrove, (unknown), Aritro Nath, Jinfeng Chen, Frederick R. Adler, Jeffrey T. Chang, Qamar J. Khan, Andrea H. Bild	4
3	Durability and Efficacy of Faricimab in Treatment‐Resistant Retinal Edema Utilizing “Real‐World” Dosing Regimens 2024 ·Journal of Ophthalmology ·(unknown), James Kwan, (unknown), Jeffrey T. Chang, David J. Ramsey, Jeffrey L. Marx, (unknown), (unknown)	4
4	Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer 2024 ·npj Breast Cancer ·Reid T. Powell, Amanda L. Rinkenbaugh, Lei Guo, Shirong Cai, Jiansu Shao, Xinhui Zhou, Xiaomei Zhang, Sabrina L. Jeter-Jones, Chunxiao Fu, Yuan Qi, (unknown), Jason B. White, Clifford Stephan, Peter J. Davies, Stacy Moulder, W. Fraser Symmans, Jeffrey T. Chang, Helen Piwnica‐Worms	2
5	Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs 2022 ·Nucleic Acids Research ·Han Liao, (unknown), (unknown), (unknown), Karen Wang, Jeffrey T. Chang, Ghislaı̀n Breton, Catherine Denicourt	59
6	Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation 2022 ·Clinical Cancer Research ·Tapsi Kumar, (unknown), Fei Yang, Jeffrey T. Chang, Alejandro Contreras, Edwin R. Parra, Haven R. Garber, Sanghoon Lee, Yiling Lu, Marion E. Scoggins, Beatriz E. Adrada, Gary J. Whitman, Banu Arun, Elizabeth A. Mittendorf, Jennifer K. Litton	8
7	Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers 2022 ·npj Breast Cancer ·Xuan Liu, Zhongqi Ge, Fei Yang, Alejandro Contreras, Sanghoon Lee, Jason B. White, Yiling Lu, Marilyne Labrie, Banu Arun, Stacy L. Moulder, Gordon B. Mills, Helen Piwnica‐Worms, Jennifer K. Litton, Jeffrey T. Chang	5
8	Knowledge-based classification of fine-grained immune cell types in single-cell RNA-Seq data 2021 ·Briefings in Bioinformatics ·Xuan Liu, Sara J.C. Gosline, Lance Pflieger, Pierre Wallet, Archana Iyer, Justin Guinney, Andrea H. Bild, Jeffrey T. Chang	11
9	CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation 2021 ·Neoplasia ·Zheng Wang, Mohit Hulsurkar, (unknown), (unknown), (unknown), Samira Naderinezhad, Lin Wang, Guoliang Zhang, Nanping Ai, Linna Li, Jeffrey T. Chang, Songlin Zhang, Ladan Fazli, Chad J. Creighton, Fang Bai, Michael Ittmann, Martin Gleave, Wenliang Li	20
10	Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy 2021 ·Nature Cancer ·Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O’Regan, Issam Makhoul, Laura M. Spring, Aditya Bardia, Frederick R. Adler, Adam L. Cohen, Jeffrey T. Chang, Qamar J. Khan, Andrea H. Bild	41
11	Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy 2020 ·Proceedings of the National Academy of Sciences ·Jason I. Griffiths, Pierre Wallet, Lance Pflieger, David D. Stenehjem, Xuan Liu, Patrick A. Cosgrove, Neena A. Leggett, Jasmine A. McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J. Moos, Frederick R. Adler, Jeffrey T. Chang, Sunil Sharma, Andrea H. Bild	67
12	Investigating the Arden hypothesis: a pilot investigation of the prevention of dark adaptation as complementary therapy for diabetic retinopathy and macular edema 2017 ·Investigative Ophthalmology & Visual Science ·David J. Ramsey, G. B. Arden, Chris Hogg, (unknown), (unknown), Jeffrey T. Chang, (unknown), (unknown), Jeffrey L. Marx	0
13	Blood transcriptomic comparison of individuals with and without autism spectrum disorder: A combined‐samples mega‐analysis 2016 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Daniel S. Tylee, Jonathan Hess, Thomas P. Quinn, (unknown), Hailiang Huang, Yanli Zhang‐James, Jeffrey T. Chang, Boryana Stamova, Frank R. Sharp, Irva Hertz‐Picciotto, Stephen V. Faraone, Sek Won Kong, Stephen J. Glatt	37
14	Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity 2016 ·Cancer Research ·Weina Zhao, Sara Prijic, (unknown), Michael J. Tisza, Yan Zuo, Lin Li, Zhi Tan, Xiaoling Chen, Sendurai A. Mani, Jeffrey T. Chang	125
15	FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer 2013 ·Cancer Research ·Brett G. Hollier, Agata A. Tinnirello, Steven J. Werden, Kurt W. Evans, Joseph H. Taube, Tapasree Roy Sarkar, Nathalie Sphyris, Maryam Shariati, (unknown), Venkata Lokesh Battula, Jason I. Herschkowitz, Rudy Guerra, Jeffrey T. Chang, Naoyuki Miura, Jeffrey M. Rosen, Sendurai A. Mani	220
16	Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer 2012 ·Breast Cancer Research ·Qing Cheng, Jeffrey T. Chang, Joseph Geradts, Leonard Μ. Neckers, Timothy Haystead, Neil L. Spector, H. Kim Lyerly	133
17	Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer 2010 ·Cancer Research ·Igor Shats, Michael L. Gatza, Jeffrey T. Chang, Seiichi Mori, Jialiang Wang, Jeremy N. Rich, Joseph R. Nevins	96
18	Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer 2009 ·Molecular Cancer Research ·Noriomi Matsumura, Zhiqing Huang, Tsukasa Baba, Paula S. Lee, Jason C. Barnett, Seiichi Mori, Jeffrey T. Chang, Wen-Lin Kuo, (unknown), Regina S. Whitaker, Joe W. Gray, Shingo Fujii, Andrew Berchuck, Susan K. Murphy	48
19	Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the Eμ- myc Model and Human Diffuse Large B-Cell Lymphoma 2008 ·Cancer Research ·Seiichi Mori, Rachel E. Rempel, Jeffrey T. Chang, Guang Yao, Anand S. Lagoo, Anil Potti, Andrea H. Bild, Joseph R. Nevins	56
20	Edinburgh-Stanford TREC-2003 Genomics Track. 2003 ·Text REtrieval Conference ·Miles Osborne, (unknown), (unknown), (unknown), Bonnie Webber, Jeffrey T. Chang, (unknown), Veronica Rotemberg, Russ B. Altman	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact